SCHEMBL13955147

SCHEMBL13955147

CCn1c(N(C)CCN)nc2c1c(=O)n(Cc1nc(C#N)c3ccccc3n1)c(=O)n2C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 13/20 0.42
▸ FAP Q12884 10/20 0.42
▸ POU2F2 P09086 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ POU2F1 P14859 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ HRH2 P25021 1/20 0.41
▸ MC4R P32245 1/20 0.41
▸ DPP8 Q6V1X1 1/20 0.41
▸ DPP9 Q86TI2 1/20 0.41
▸ GHSR Q92847 1/20 0.41
▸ MAOB P27338 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ KCNH2 Q12809 3/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13936232 0.91 DPP4 (0.51) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL12650019 0.88 DPP4 (0.51) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL13954984 0.82 DPP4 (0.52) DPP4MAOBTHRBMAPTALDH1A1
SCHEMBL13954992 0.81 DPP4 (0.40) DPP4FAPMAOBTHRBMAPT
SCHEMBL13954915 0.81 KMT2A (0.56) DPP4MAOBALDH1A1
SCHEMBL20895844 0.81 DPP4 (0.49) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL1772436 0.80 DPP4 (0.63) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL8271567 0.80 DPP4 (0.53) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL8273215 0.79 DPP4 (0.61) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL9290323 0.77 HSD17B10 (0.43) DPP4FAPMAOBTHRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 — — US disclosed
Send feedback